HealthCap VII L.P. 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-15 5:08 pm Unchanged |
2022-10-26 | 13D | Aprea Therapeutics, Inc. APRE |
HealthCap VII L.P. | 118,305 4.500% |
0 (Unchanged) |
Filing |
| 2022-06-30 4:34 pm Unchanged |
2022-06-30 | 13D | Aprea Therapeutics, Inc. APRE |
HealthCap VII L.P. | 118,305 10.100% |
0 (Unchanged) |
Filing |
| 2021-10-15 4:50 pm Unchanged |
2021-10-13 | 13D | Aprea Therapeutics, Inc. APRE |
HealthCap VII L.P. | 118,305 11.200% |
0 (Unchanged) |
Filing |